
Prior authorization, step therapy and shifting coverage rules keep patients from obesity drugs with proven benefits, an endocrinologist argues — and the long-term savings make the case for broader access.
Joseph Scherger, MD, explains why
Joseph Scherger, MD, says fee-for-service doesn’t pay well for primary care services and requires greater overhead than direct payment.




